-
Article | 2017.08.08
General Recommendations
VACCINATIONSBefore traveling abroad, a vaccination schedule should be drawn up based on two criteria:Administrative obligation: the measures adopted by the country to protect against an infectious risk from another country, rather than the actual risks for the traveler.The actual risks for the traveler: these vary depending on the health situation of the country they are going to, the...
-
Document de presse | 2004.03.17
World Tuberculosis Day (March 24): The Institut Pasteur engaged in the fight
With a third of the world's population infected, 2 million deaths and 8.5 million new cases each year, tuberculosis (TB) is the number two infectious disease in the world after AIDS, without sparing France, where 6300 new cases occurred last year. The prevalence of the resistance to antibiotics and the emergence of multiresistance are worrying at the international level, and is a risk for...
-
Document de presse | 2012.04.18
A new hope in the fight against tuberculosis
Researchers from the Institut Pasteur and Inserm, in collaboration with researchers from the University of Pisa, have uncovered the key role played by specific proteins in the virulence of the mycobacterium responsible for tuberculosis, Mycobacterium tuberculosis. They were able to create an attenuated strain of the mycobacterium, which confers a better protection against tuberculosis than the...
-
News | 2023.12.19
Tick-borne viruses evade innate immunity
Flaviviruses are pathogens transmitted by ticks that can cause serious diseases including neurological disorders. A study conducted at the Institut Pasteur reveals how these viruses can slip between the cracks of immunity.
-
Événement | 2022.10.28
A bicentenary tribute to Louis Pasteur, Foreign Member of the Royal Society
To celebrate the bicentenary of Louis Pasteur's birth and pay tribute to this scientist who was a Foreign Member of the Royal Society, the Institut Pasteur and the Académie des sciences are organizing a symposium with support from the Royal Society. This symposium will present cutting-edge research in Louis Pasteur’s own research areas and promote international cooperation in science and...
-
News | 2022.11.24
From bacterial poisons to toxins: the early work of the Pasteurians
Jean-Marc Cavaillon, Honorary Professor at the Institut Pasteur, presents an overview of the discoveries that have shaped our understanding of bacterial toxins.
-
News | 2024.12.09
Lessons learned from the COVID-19 crisis: improving protection through early response, rapid tracking and impact monitoring
Scientific experts from 13 Western European countries have recently completed a review of key lessons learned from the way the COVID-19 pandemic was handled. Two key findings have emerged. Firstly, death rates were lower in countries that took measures early. Secondly, the need for a surveillance system capable of quickly tracking the community spread of a virus and its impact on hospitals was...
-
Document de presse | 2012.02.09
Newly characterized dengue virus antibody shows promise
Research teams from the Institut Pasteur, the CNRS, and Inserm have recently characterized the structure and mechanism of action of an antibody that successfully neutralizes all four strains of the dengue virus in mice models. Their groundbreaking work represents major progress for research efforts that hope to develop an effective vaccine to combat this disease. This study was published February...
-
Document de presse | 2007.07.12
Leptospirosis: the first virulence gene identified
Although leptospirosis is one of the so-called "neglected" diseases, it still causes some 500,000 severe cases in humans around the world each year and also comprises a veterinary problem. A century after the pathogenic agent that causes the disease was found, researchers at the Institut Pasteur have discovered a gene that is essential to the bacteria's virulence. Their work,...
-
Document de presse | 2005.02.24
"The Sword and the Shield" - How bacteria develop their virulence by creating multiple variants
Researchers at Institut Pasteur and the French National Institute of Health and Medical Research (Inserm), in association with the Imperial College of London, recently explained why Shigella flexneri bacteria, which cause fatal dysenteries, have several variants (serotypes), thus optimizing their virulence. This discovery, published in Science, is essential to vaccine research as, in order to be...